Molecular testing plays a critical role in protecting newborn health. Public health laboratories worldwide rely on sensitive, reliable tools to rapidly detect genetic and metabolic disorders in newborns.

Dried blood spots — the most common sample type — are often low-input and may contain inhibitors that reduce test performance. To meet these challenges, molecular tools must be tough, sensitive, and optimized for these complex workflows.

Quantabio supports advances in newborn screening by providing robust and highly sensitive amplification and extraction tools. Our PCR/qPCR chemistries, innovative DNA extraction reagents along with comprehensive next generation sequencing (NGS) reagents are designed for accuracy, speed, and reliability in high-throughput public health laboratories.